Allston, MA, United States of America

David Deluca

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Deluca. Retrieved from https://idiyas.com/inventor/david-deluca

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Deluca: Innovator in Tissue Typing Technology

Introduction

David Deluca is a notable inventor based in Allston, Massachusetts. He has made significant contributions to the field of tissue typing through his innovative work. His expertise and dedication have led to advancements that are crucial for medical diagnostics and transplant compatibility.

Latest Patents

David Deluca holds a patent for an "Oligonucleotide array for tissue typing." This invention involves oligonucleotide-based microarrays that are particularly useful for high-resolution diagnostic evaluations. These microarrays play a vital role in determining donor and recipient transplant compatibility, especially in HLA tissue typing.

Career Highlights

Deluca is associated with the Dana-Farber Cancer Institute, where he applies his knowledge and skills to further research in cancer treatment and diagnostics. His work has been instrumental in enhancing the understanding of tissue compatibility in transplant procedures.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues such as Ellis L Reinherz and Vladimir Brusic. These partnerships have fostered a collaborative environment that promotes innovation and research excellence.

Conclusion

David Deluca's contributions to tissue typing technology exemplify the impact of innovation in the medical field. His work not only advances scientific understanding but also improves patient outcomes in transplant procedures.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…